Mesenchymal Stem Cells as a Biological Drug for Heart Disease. Issue 3 (17th July 2015)

• Record Type: Journal Article
• Authors: Sanina, Cristina; Hare, Joshua M.
• Is Part Of: Circulation research. Volume 117:Issue 3(2015)
• Publication Date: 2015-07-17
• Subjects: Cardiovascular system -- Periodicals; Blood -- Circulation -- Periodicals; Blood Circulation; Cardiovascular System; Vascular Diseases; Sang -- Circulation -- Périodiques; Appareil cardiovasculaire -- Périodiques; 612.1
• DOI: 10.1161/CIRCRESAHA.117.306306
• Languages: English
• ISSNs: 0009-7330

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p>Cell-based treatment represents a new generation in the evolution of biological therapeutics. A prototypic cell-based therapy, the mesenchymal stem cell, has successfully entered phase III pivotal trials for heart failure, signifying adequate enabling safety and efficacy data from phase I and II trials. Successful phase III trials can lead to approval of a new biological therapy for regenerative medicine.</p> </sec> </abstract>